source Post navigation Once-weekly dose of insulin efsitora alfa delivers A1C reduction consistent with the most advanced daily insulin in people with type 2 diabetes | Eli Lilly and Company – Investors | Eli Lilly and Company Lilly's efsitora shows potential as rival to Awiqli – The Pharma Letter